Status:
COMPLETED
Efficacy and Safety of FTY720 in Patients Who Receive a Kidney Transplantation
Lead Sponsor:
Novartis Pharmaceuticals
Conditions:
Kidney Transplantation
Eligibility:
All Genders
18-65 years
Phase:
PHASE3
Brief Summary
In patients who receive an organ transplant, their body considers this organ as foreign and attempts to destroy it. This is called rejection. All patients who receive an organ transplant, will take a ...
Eligibility Criteria
Inclusion
- First kidney transplantation
- Male and female patients
- Between 18 and 65 years old
Exclusion
- Patient in need of multi-organ transplant
- Patients with history of cardiac arrest
- Patients with any past or present malignancy
Key Trial Info
Start Date :
April 1 2004
Trial Type :
INTERVENTIONAL
End Date :
Estimated Enrollment :
140 Patients enrolled
Trial Details
Trial ID
NCT00098735
Start Date
April 1 2004
Last Update
November 18 2016
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.